• Latest Posts

First Stem Cell Therapy for Liver Failure Shows Promise in First Human Trials

Genfit Gets Ready to Launch Drug for Untreated Liver Disease Raising €120M

NASH Leader goes Pediatric with Clinical Trial Launch in US

New Dutch Biotech Sails Straight into Phase II with €25M Series A to Treat NASH

More News! 5 Dec 2017

PayPal Co-Founder Backs Israeli Biotech Attacking NASH with an Antibody

NASH Leader Signs Up for EU Project to Fight Deadly Liver Disease

German Pharma and Biotech Gang Up on NASH in an Exciting Collaboration

Genfit Gets €180M Cash Injection to Bring its Pipeline to Market

These Three Fields Are Proving Biotech is The Innovation Powerhouse in Healthcare